Weak humoral immune reactivity among residents of long-term care facilities following one dose of the BNT162b2 mRNA COVID-19 vaccine
Mark A. Brockman, Francis Mwimanzi, Yurou Sang, Kurtis Ng, Olga Agafitei, Siobhan Ennis, Hope Lapointe, Landon Young, Gisele Umviligihozo, Laura Burns, Chanson Brumme, Victor Leung, Julio S.G. Montaner, Daniel Holmes, Mari DeMarco, Janet Simons, Masa Niikura, Ralph Pantophlet, Marc G. Romney, Zabrina L. Brumme
doi: https://doi.org/10.1101/2021.03.17.21253773
Mark A. Brockman
1Faculty of Health Sciences, Simon Fraser University, Burnaby BC, Canada
2Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby BC, Canada
3British Columbia Centre for Excellence in HIV/AIDS, Vancouver BC, Canada
Francis Mwimanzi
1Faculty of Health Sciences, Simon Fraser University, Burnaby BC, Canada
Yurou Sang
1Faculty of Health Sciences, Simon Fraser University, Burnaby BC, Canada
Kurtis Ng
1Faculty of Health Sciences, Simon Fraser University, Burnaby BC, Canada
Olga Agafitei
1Faculty of Health Sciences, Simon Fraser University, Burnaby BC, Canada
Siobhan Ennis
1Faculty of Health Sciences, Simon Fraser University, Burnaby BC, Canada
Hope Lapointe
3British Columbia Centre for Excellence in HIV/AIDS, Vancouver BC, Canada
Landon Young
4Division of Medical Microbiology and Virology, St. Paul’s Hospital, Vancouver BC, Canada
Gisele Umviligihozo
1Faculty of Health Sciences, Simon Fraser University, Burnaby BC, Canada
Laura Burns
6Department of Pathology and Laboratory Medicine, St. Paul’s Hospital, Vancouver BC, Canada
Chanson Brumme
3British Columbia Centre for Excellence in HIV/AIDS, Vancouver BC, Canada
5Department of Medicine, University of British Columbia, Vancouver BC, Canada
Victor Leung
4Division of Medical Microbiology and Virology, St. Paul’s Hospital, Vancouver BC, Canada
7Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver BC, Canada
Julio S.G. Montaner
3British Columbia Centre for Excellence in HIV/AIDS, Vancouver BC, Canada
6Department of Pathology and Laboratory Medicine, St. Paul’s Hospital, Vancouver BC, Canada
Daniel Holmes
6Department of Pathology and Laboratory Medicine, St. Paul’s Hospital, Vancouver BC, Canada
7Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver BC, Canada
Mari DeMarco
6Department of Pathology and Laboratory Medicine, St. Paul’s Hospital, Vancouver BC, Canada
7Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver BC, Canada
Janet Simons
6Department of Pathology and Laboratory Medicine, St. Paul’s Hospital, Vancouver BC, Canada
7Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver BC, Canada
Masa Niikura
1Faculty of Health Sciences, Simon Fraser University, Burnaby BC, Canada
Ralph Pantophlet
1Faculty of Health Sciences, Simon Fraser University, Burnaby BC, Canada
2Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby BC, Canada
Marc G. Romney
4Division of Medical Microbiology and Virology, St. Paul’s Hospital, Vancouver BC, Canada
7Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver BC, Canada
Zabrina L. Brumme
2Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby BC, Canada
3British Columbia Centre for Excellence in HIV/AIDS, Vancouver BC, Canada
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted March 24, 2021.
Weak humoral immune reactivity among residents of long-term care facilities following one dose of the BNT162b2 mRNA COVID-19 vaccine
Mark A. Brockman, Francis Mwimanzi, Yurou Sang, Kurtis Ng, Olga Agafitei, Siobhan Ennis, Hope Lapointe, Landon Young, Gisele Umviligihozo, Laura Burns, Chanson Brumme, Victor Leung, Julio S.G. Montaner, Daniel Holmes, Mari DeMarco, Janet Simons, Masa Niikura, Ralph Pantophlet, Marc G. Romney, Zabrina L. Brumme
medRxiv 2021.03.17.21253773; doi: https://doi.org/10.1101/2021.03.17.21253773
Weak humoral immune reactivity among residents of long-term care facilities following one dose of the BNT162b2 mRNA COVID-19 vaccine
Mark A. Brockman, Francis Mwimanzi, Yurou Sang, Kurtis Ng, Olga Agafitei, Siobhan Ennis, Hope Lapointe, Landon Young, Gisele Umviligihozo, Laura Burns, Chanson Brumme, Victor Leung, Julio S.G. Montaner, Daniel Holmes, Mari DeMarco, Janet Simons, Masa Niikura, Ralph Pantophlet, Marc G. Romney, Zabrina L. Brumme
medRxiv 2021.03.17.21253773; doi: https://doi.org/10.1101/2021.03.17.21253773
Subject Area
Subject Areas
- Addiction Medicine (408)
- Allergy and Immunology (720)
- Anesthesia (214)
- Cardiovascular Medicine (3042)
- Dermatology (258)
- Emergency Medicine (456)
- Epidemiology (12963)
- Forensic Medicine (12)
- Gastroenterology (848)
- Genetic and Genomic Medicine (4773)
- Geriatric Medicine (441)
- Health Economics (747)
- Health Informatics (3028)
- Health Policy (1096)
- Hematology (405)
- HIV/AIDS (952)
- Medical Education (450)
- Medical Ethics (119)
- Nephrology (490)
- Neurology (4545)
- Nursing (242)
- Nutrition (671)
- Oncology (2365)
- Ophthalmology (666)
- Orthopedics (264)
- Otolaryngology (332)
- Pain Medicine (296)
- Palliative Medicine (86)
- Pathology (512)
- Pediatrics (1232)
- Primary Care Research (515)
- Public and Global Health (7136)
- Radiology and Imaging (1587)
- Respiratory Medicine (940)
- Rheumatology (456)
- Sports Medicine (396)
- Surgery (505)
- Toxicology (63)
- Transplantation (218)
- Urology (187)